| 000 | 01622 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515185908.0 | ||
| 264 | 0 | _c20091201 | |
| 008 | 200912s 0 0 eng d | ||
| 022 | _a1095-6859 | ||
| 024 | 7 |
_a10.1016/j.ygyno.2009.08.024 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJoly, F | |
| 245 | 0 | 0 |
_aWeekly combination of topotecan and gemcitabine in early recurrent ovarian cancer patients: a French multicenter phase II study. _h[electronic resource] |
| 260 |
_bGynecologic oncology _cDec 2009 |
||
| 300 |
_a382-8 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
| 650 | 0 | 4 |
_aDeoxycytidine _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 |
_aTopotecan _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aGemcitabine |
| 700 | 1 | _aPetit, T | |
| 700 | 1 | _aPautier, P | |
| 700 | 1 | _aGuardiola, E | |
| 700 | 1 | _aMayer, F | |
| 700 | 1 | _aChevalier-Place, A | |
| 700 | 1 | _aDelva, R | |
| 700 | 1 | _aSevin, E | |
| 700 | 1 | _aHenry-Amar, M | |
| 700 | 1 | _aBourgeois, H | |
| 773 | 0 |
_tGynecologic oncology _gvol. 115 _gno. 3 _gp. 382-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ygyno.2009.08.024 _zAvailable from publisher's website |
| 999 |
_c19170075 _d19170075 |
||